Johnson & Johnson (JNJ): FY25 Q2 earnings call, Jul 16, 2025
No Kalshi or Polymarket word markets were listed for Johnson & Johnson’s Jul 16, 2025 earnings call (FY25 Q2). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
2 matches for “Litigation”; 2 quoted, at least 25 words apart.
…of $0.7 billion in the prior year primarily driven by lower talc litigation expense in 2025 and the $0.4 billion loss on the sale of…
…the $14.5 billion intracellular acquisition, which closed on April 2. Regarding talk litigation, we expect the [ Daubert ] hearing to commence this fall and…
Agents: this page as TSV at /api/v1/appearances/johnson-and-johnson:2025-07-16:earnings_call · words: /api/v1/brief?appearance=johnson-and-johnson:2025-07-16:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP